current role of vegf-targeted therapy in ovarian cancer
Published 5 years ago • 285 plays • Length 7:55Download video MP4
Download video MP3
Similar videos
-
8:14
targeting vegf in advanced ovarian cancer
-
0:45
dr. mcdermott on the role of vegf targeted therapy in rcc
-
2:03
investigating the role of vegf in targeted therapy for cancer
-
8:05
targeted therapy options for advanced ovarian cancer
-
4:31
frontline vegf inhibition in advanced ovarian cancer
-
1:08
dr. dottino on targeted therapies in ovarian cancer
-
0:50
challenges with targeted therapies in ovarian cancer
-
58:19
the implications of recent datasets for the current and future management of nsclc egfr mutations
-
8:41
use of vegf-targeted tyrosine kinase inhibitors
-
7:40
i/o combination strategies in ovarian cancer
-
0:43
role of serum vegf-a biomarker for early diagnosis of ovarian cancer instead of ca-125 | rtcl.tv
-
0:57
combined inhibition of parp and vegf in gastric cancer
-
5:02
novel agents and the future treatment of ovarian cancer
-
6:16
upfront antiangiogenic therapy in advanced ovarian cancer
-
4:55
managing recurrent advanced ovarian cancer in the current era
-
5:17
vegf and pd-1 inhibition in advanced gastric/gej cancer
-
5:07
improvements in advanced ovarian cancer
-
2:03
prognosis after more than 3 lines of therapy in ovarian cancer
-
2:05
future directions in high-risk ovarian cancer